SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2633The contingent payments are non-transferrable. Though that must be a bookkepingkeokalani'nui-7/15/2008
2632VPHM, nice premium, market blasting VPHM BOSTON (MarketWatch) -- ViroPharma Inctom pope-7/15/2008
2631At yesterdays close, all you can lose is a few cents and maybe you get lucky. Gorkrw-7/15/2008
2630It really is peanuts for most of the interested parties so who the heck knows. kenhott-7/15/2008
2629Forgetting the structural informatics service side. I don't know how to valurkrw-7/14/2008
2628BVF looking for a better deal on SGX: >>SGX Holder Plans To Explore Altertuck-7/14/2008
2627Paragraphs on this takeover in WSJ today, July 14th 08. Credit Crunch Opens Patkenhott-7/14/2008
2626I wouldn't think capital gains tax changes would be a big driver of m&a rkrw-7/11/2008
2625The Obama capital gains tax proposals appear to be bringing forward some M&Anigel bates-7/11/2008
2624Merger documents are up at sec.gov. Search for "background to the merger.&qrkrw-7/11/2008
2623SGXP looks like it traded as high as 3.23 this morning - but on very low volume.Steve Lokness-7/11/2008
2622Drugmaker Wyeth, based in Madison, New Jersey, already shareholder in PSC, mightB O Trust-7/11/2008
2621Good that there is now significant opposition to this BAD deal. FDA decision isB O Trust-7/10/2008
2620I'm sure there are plenty of unsaleable biotechs. Reverse merge candidates rkrw-7/10/2008
2619<i>With valuations so beaten down, it seems like almost any decent beaten DewDiligence_on_SI-7/10/2008
2618<i>Not sure why the stock is trading around [CHF] 129 given it is cash.<DewDiligence_on_SI-7/10/2008
2617I think it should scare some shorts at some point. Existing relationships, stronrkrw-7/10/2008
2616Taken out for about $900m for what is left out. Not sure why the stock is tradikenhott-7/10/2008
2615Mgt may have gotten a push from Lilly. Depending on the the acquirer of course,kenhott-7/10/2008
2614Updated buyout table for Speedel deal: siliconinvestor.comDewDiligence_on_SI-7/10/2008
2613NOVARTIS ACQUIRING ADDITIONAL SHARES OF SPEEDEL FROM FIVE SIGNIFICANT SPEEDEL SHscaram(o)uche-7/10/2008
2612Emergent BioSolutions Sues Biotech Firm Rockville Vaccine Maker Says Protein ScDoc Bones-7/10/2008
2611I never really followed GlycoFi, and it looks to me like a good vaccine platformBiotech Jim-7/9/2008
2610<i>This goes to show that technology companies just aren't worth the iDewDiligence_on_SI-7/9/2008
2609and also shows how transitioning from a technology to a drug company is really hrkrw-7/9/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News